Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects (DGCLFT2DM)
Sponsor: Rio de Janeiro State Research Supporting Foundation (FAPERJ)
This PHASE3 trial investigates Diabetes Mellitus, Type 2 and Non-alcoholic Fatty Liver Disease and is currently completed. Rio de Janeiro State Research Supporting Foundation (FAPERJ) leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jul 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
Jan 2017 — Jul 2017 [monthly]
Recruiting PHASE3
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rio de Janeiro State Research Supporting Foundation (FAPERJ)
- Universidade Federal do Rio de Janeiro
For direct contact, visit the study record on ClinicalTrials.gov .